{"count": 4, "results": [{"_id": "35847477", "pmid": 35847477, "pmcid": "PMC9277541", "title": "Metformin and the risk of dementia based on an analysis of 396,332 participants", "journal": "Ther Adv Chronic Dis", "authors": ["Ji S", "Zhao X", "Zhu R", "Dong Y", "Huang L", "Zhang T"], "date": "2022-07-09T00:00:00Z", "doi": "10.1177/20406223221109454", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "20406223221109454", "score": 50258.754, "text_hl": "The @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ cohort had an increased risk of all-cause @DISEASE_Dementia @DISEASE_MESH:D003704 @@@dementia@@@ (HR: 1.66, 95% CI: 1.35-2.04) @DISEASE_Dementia @DISEASE_MESH:D003704 @@@Dementia@@@; @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@PD@@@; @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@AD@@@; @<m>DISEASE_Dementia_Vascular</m> @DISEASE_MESH:D015140 @@@vascular dementia@@@ HR Adjustment for age; sex; Charlson Comorbidity Index   Brakedal et al. ", "citations": {"NLM": "Ji S, Zhao X, Zhu R, Dong Y, Huang L, Zhang T. Metformin and the risk of dementia based on an analysis of 396,332 participants Ther Adv Chronic Dis. 2022;13():20406223221109454. PMID: 35847477", "BibTeX": "@article{35847477, title={Metformin and the risk of dementia based on an analysis of 396,332 participants}, author={Ji S and Zhao X and Zhu R and Dong Y and Huang L and Zhang T}, journal={Ther Adv Chronic Dis}, volume={13}, pages={20406223221109454}}"}}, {"_id": "36786091", "pmid": 36786091, "title": "Collocation of metformin and dipeptidyl peptidase-4 inhibitor is associated with increased risk of diabetes-related vascular dementia: A single hospital study in Northern Taiwan.", "journal": "Expert Opin Investig Drugs", "authors": ["Tzeng IS", "Hsieh TH"], "date": "2023-02-01T00:00:00Z", "doi": "10.1080/13543784.2023.2178417", "meta_date_publication": "2023 Feb", "meta_volume": "32", "meta_issue": "2", "meta_pages": "171-176", "score": 50255.9, "text_hl": "Collocation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and dipeptidyl peptidase-4 inhibitor is associated with increased risk of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@-related @<m>DISEASE_Dementia_Vascular</m> @DISEASE_MESH:D015140 @@@vascular dementia@@@: A single hospital study in Northern Taiwan.", "citations": {"NLM": "Tzeng IS, Hsieh TH. Collocation of metformin and dipeptidyl peptidase-4 inhibitor is associated with increased risk of diabetes-related vascular dementia: A single hospital study in Northern Taiwan. Expert Opin Investig Drugs. 2023 Feb;32(2):171-176. PMID: 36786091", "BibTeX": "@article{36786091, title={Collocation of metformin and dipeptidyl peptidase-4 inhibitor is associated with increased risk of diabetes-related vascular dementia: A single hospital study in Northern Taiwan.}, author={Tzeng IS and Hsieh TH}, journal={Expert Opin Investig Drugs}, volume={32}, number={2}, pages={171-176}}"}}, {"_id": "33935082", "pmid": 33935082, "title": "The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study.", "journal": "J Alzheimers Dis", "authors": ["Kim WJ", "Noh JH", "Han K", "Park CY"], "date": "2021-01-01T00:00:00Z", "doi": "10.3233/JAD-201535", "meta_date_publication": "2021", "meta_volume": "81", "meta_issue": "3", "meta_pages": "1263-1272", "score": 50255.375, "text_hl": "RESULTS: Dual therapy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) + dipeptidyl peptidase-4 inhibitor (DPP-4i), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ + @CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@thiazolidinedione@@@ (@CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@TZD@@@), and @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylurea@@@ (@CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@SU@@@) + @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@ (@CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@TZD@@@) were significantly associated with all-cause @DISEASE_Dementia @DISEASE_MESH:D003704 @@@dementia@@@ (HR = 0.904, 0.804, and 0.962, respectively) and @<m>DISEASE_Dementia_Vascular</m> @DISEASE_MESH:D015140 @@@VaD@@@ (HR = 0.865, 0.725, and 0.911, respectively), compared with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ + @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@SU@@@. ", "citations": {"NLM": "Kim WJ, Noh JH, Han K, Park CY. The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study. J Alzheimers Dis. 2021;81(3):1263-1272. PMID: 33935082", "BibTeX": "@article{33935082, title={The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study.}, author={Kim WJ and Noh JH and Han K and Park CY}, journal={J Alzheimers Dis}, volume={81}, number={3}, pages={1263-1272}}"}}, {"_id": "28583443", "pmid": 28583443, "title": "Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry", "authors": ["Kuan YC", "Huang KW", "Lin CL", "Hu CJ", "Kao CH"], "date": "2017-10-03T00:00:00Z", "doi": "10.1016/j.pnpbp.2017.06.002", "meta_date_publication": "2017 Oct 3", "meta_volume": "79", "meta_issue": "Pt B", "meta_pages": "77-83", "score": 50046.39, "text_hl": "Moreover, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exposure increased the risk of @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@ (HR: 2.13, 95% CI=1.20-3.79) and @<m>DISEASE_Dementia_Vascular</m> @DISEASE_MESH:D015140 @@@vascular dementia@@@ (HR: 2.30, 95% CI=1.25-4.22). ", "citations": {"NLM": "Kuan YC, Huang KW, Lin CL, Hu CJ, Kao CH. Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):77-83. PMID: 28583443", "BibTeX": "@article{28583443, title={Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.}, author={Kuan YC and Huang KW and Lin CL and Hu CJ and Kao CH}, journal={Prog Neuropsychopharmacol Biol Psychiatry}, volume={79}, number={Pt B}, pages={77-83}}"}}]}